Streptomycin Injectable 1 g/2 mL, 2 g/2 mL Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV/IM)

Available Strengths: 1 g/2 mL, 2 g/2 mL

Reference Brands: Generic formulations marketed under different names

Category: Antibiotics

Streptomycin inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing improper protein formation and bacterial death. It is effective against tuberculosis and severe bacterial infections. Benefits include rapid bactericidal activity, high efficacy against multidrug-resistant bacteria, and use in critical care settings when administered properly.

Product Description:

Streptomycin injectable is approved in the EU and US for treating tuberculosis and serious bacterial infections. In the EU, brands are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval depends on comprehensive clinical data, with generic formulations available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its critical role in combating MDR bacteria, strict prescribing controls and safety protocols are enforced. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access consistent with European and US standards for safe, effective antibiotic therapy.